Skip to Content Facebook Feature Image

Truvian Appoints Renowned Physician-Scientist and Diagnostic Innovator Dr. Michael Mina as Chief Medical and Strategy Officer

News

Truvian Appoints Renowned Physician-Scientist and Diagnostic Innovator Dr. Michael Mina as Chief Medical and Strategy Officer
News

News

Truvian Appoints Renowned Physician-Scientist and Diagnostic Innovator Dr. Michael Mina as Chief Medical and Strategy Officer

2026-01-07 21:03 Last Updated At:21:11

SAN DIEGO--(BUSINESS WIRE)--Jan 7, 2026--

Truvian Health (“Truvian”), a transformational diagnostics company redefining healthcare, today announced the appointment of Michael J. Mina, MD, PhD, as Chief Medical and Strategy Officer. Dr. Mina, a former Harvard professor and a globally recognized leader in epidemiology and diagnostic technology, joins Truvian as the company accelerates its mission to decentralize blood testing following the recent FDA clearance of its TruVerus™, a multimodal blood analyzer.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260107414515/en/

In his new role with Truvian, Dr. Mina will oversee clinical and regulatory strategy, while advancing strategic partnerships and opportunities across the biomedical and technology sector to accelerate Truvian’s market adoption and growth.

Dr. Mina’s career has been defined by his work at the intersection of immunology, diagnostics, bioengineering, and public health. A former professor at the Harvard T.H. Chan School of Public Health and Harvard Medical School, his research has fundamentally shaped aspects of our modern understanding of the role diagnostics play in disease prevention and health system innovation. During the COVID-19 pandemic, Dr. Mina emerged as a leading global voice on testing strategy, advising governments and industry leaders on how to use technology to build more resilient health systems.

"We are entering a pivotal chapter at Truvian as we move toward commercialization of the TruVerus platform," said Dena Marrinucci, PhD, Co-Founder and Chief Operating Officer of Truvian. "Dr. Mina’s unique perspective as both a clinician and a technologist is a perfect match for our culture of rigorous science and accessibility. His track record of bridging the gap between academic discovery and practical, large-scale deployment will be invaluable as we work to place lab-quality diagnostics directly into the hands of healthcare providers wherever care happens."

Prior to joining Truvian, Dr. Mina served as the associate director of molecular diagnostics at Brigham and Women’s Hospital and the Broad Institute of MIT and Harvard. In addition to his clinical and academic contributions, he is a seasoned entrepreneur, having helped lead and exit numerous biotechnology companies and is a lecturer at the M.I.T. Sloan School of Management. His expertise in commercializing next-generation diagnostic technologies, including digital health platforms that link testing with telemedicine, aligns with Truvian’s mission to decentralize the traditional lab model.

"Truvian is doing what many thought was impossible: miniaturizing and automating the gold-standard of lab testing without compromising on accuracy," said Dr. Mina. "Throughout my career, I have advocated for diagnostics that are not just precise, but also more accessible to more people and that can offer results when we need them most – at the point of care. Truvian is doing just that and I am thrilled to join Dena and the entire Truvian team to help realize a future where diagnostic data empowers providers to deliver faster, more informed care with results available in minutes, all towards building a more resilient healthcare system.”

About Truvian

Truvian Health is a transformational diagnostics company redefining healthcare through its FDA-cleared, multimodal blood testing platform. Built on a foundation of scientific integrity and relentless innovation, Truvian empowers providers and patients with convenient, accurate, timely, and comprehensive testing – without compromise. Truvian’s expanding portfolio of assays delivers central lab‑quality results available to anyone, anywhere. Learn more at truvianhealth.com or follow us on LinkedIn.

Disclaimer:

This press release contains forward‑looking statements based on current expectations and plans. These statements involve risks and uncertainties that could cause actual results to differ from what we expect. We do not promise to update any forward‑looking statements to reflect future events.

Dr. Michael Mina, Chief Medical and Strategy Officer, Truvian Health

Dr. Michael Mina, Chief Medical and Strategy Officer, Truvian Health

LONDON (AP) — Britain braced for potentially life-threatening winds, rains and snowfall as a severe storm rolled in from the southwest of England on Thursday during what already has been one of the country's worst cold snaps in years.

Forecasters said the brunt of the storm would hit central England with as much as 30 centimeters (12 inches) of snowfall in just a few hours, which could disrupt schools, travel and commerce, especially in rural areas.

The Met Office, Britain’s national meteorological service, issued a rare red weather warning — its highest — for the southwest of England where wind gusts up to 100 mph (160 kph) were expected in Cornwall and the Isles of Scilly. It warned of “dangerous, stormy” winds and very large waves, damage to buildings and homes, flying debris, widespread travel cancellations and power cuts.

Red weather warnings are issued when the forecaster considers it to be “very likely that there will be a risk to life, with substantial disruption to travel, energy supplies and possibly widespread damage to property and infrastructure.”

Storm Goretti, named by the French weather service France Meteo, was expected to leave Britain’s shores on Friday and then impact other parts of northwest Europe that already have endured snow, ice and freezing temperatures in recent days.

Neil Armstrong, chief forecaster at the Met Office, described Goretti as a “multi-hazard event” with heavy rain, strong winds and snow. “This is a complex spell of severe weather,” he said.

The Met Office also issued amber warnings for many parts of the U.K. These have an “increased likelihood of impacts from severe weather," meaning there is the possibility of travel delays, road and rail closures, flight cancellations, power cuts and potential risk to life and property.

the U.K. Health Security Agency also extended amber cold weather alerts acroos all regions of England until Jan. 12, meaning severe health impacts are expected. Officials expect a rise in deaths, particularly among those aged 65 and over or with health conditions, with impacts also possible on younger age groups.

Many parts of Wales, northern England and Scotland have been blanketed over the past few days with snow that has led to numerous school closures and travel disruption.

In the Netherlands, the bad weather eased on Thursday, helping Amsterdam’s Schiphol Airport, which saw hundreds of flights canceled on each of the first three days of the working week. However, it was briefly hit by a power outage in the morning.

Dutch national carrier KLM said there were still long lines of passengers at the airport but added that it was “doing everything possible to ensure departing passengers leave on time.”

On the opposite side of Europe, in the southeastern countries of the Balkans, bad weather was continuing to bring widespread disruption.

In Serbia, which celebrated the orthodox Christmas on Jan. 6, heavy snow has snarled traffic while temperatures in Slovenia have fallen to -25 degrees Celsisus (minus 13 Fahrenheit.

Bosnia, Kosovo and Montenegro faced floods after heavy rainfall and snow caused local rivers to overflow their banks, forcing dozens of people to evacuate their homes.

Mike Corder in The Hague, Netherlands and Jovana Gec in Belgrade contributed to this report.

Stranded travellers queue at the information desk at Schiphol airport in Amsterdam, Netherlands, Wednesday, Jan. 7, 2026, where more than 1,000 people spent the night as snow and ice that is pummeling parts of Europe grounded hundreds of flights and choked highways and railroads. (AP Photo/Peter Dejong)

Stranded travellers queue at the information desk at Schiphol airport in Amsterdam, Netherlands, Wednesday, Jan. 7, 2026, where more than 1,000 people spent the night as snow and ice that is pummeling parts of Europe grounded hundreds of flights and choked highways and railroads. (AP Photo/Peter Dejong)

Bamburgh Castle surrounded by snow in Bamburgh, England, Tuesday, Jan. 6, 2026. (Owen Humphreys/PA via AP)

Bamburgh Castle surrounded by snow in Bamburgh, England, Tuesday, Jan. 6, 2026. (Owen Humphreys/PA via AP)

A woman covers herself with a blanket against the cold next to a banking machine in Frankfurt, Germany, Wednesday, Jan. 7, 2026. (AP Photo/Michael Probst)

A woman covers herself with a blanket against the cold next to a banking machine in Frankfurt, Germany, Wednesday, Jan. 7, 2026. (AP Photo/Michael Probst)

People walk in front of the Reichstag Building, home of the German parliament Bundestag, on a snowy winter day in Berlin, Germany, Thursday, Jan. 8, 2026. (AP Photo/Markus Schreiber)

People walk in front of the Reichstag Building, home of the German parliament Bundestag, on a snowy winter day in Berlin, Germany, Thursday, Jan. 8, 2026. (AP Photo/Markus Schreiber)

Lost Earth Adventures' instructor Mick Ellerton climbs a frozen waterfall in Gordale Scar near Malham Cove in the Yorkshire Dales National Park, as ice warnings are in place across the UK ahead of a storm which is set to bring heavy snow later in the week, on Wednesday Jan. 7, 2026. (Danny Lawson/PA via AP)

Lost Earth Adventures' instructor Mick Ellerton climbs a frozen waterfall in Gordale Scar near Malham Cove in the Yorkshire Dales National Park, as ice warnings are in place across the UK ahead of a storm which is set to bring heavy snow later in the week, on Wednesday Jan. 7, 2026. (Danny Lawson/PA via AP)

Recommended Articles